Pathway-based Screening

Pathway-Based Screening is a phenotypic screening approach that identifies bioactive compounds or genetic perturbations by assessing their effects on predefined biological pathways rather than on individual molecular targets or gross cellular phenotypes.

41

Publications

1.3K

Citations

310

Authors

119

Institutions

Publications per year

2017–2026

12

Authors

310

  1. IS
    Imran Shah

    Environmental Protection Agency, United States

    2 publications · 33 citations

    2

    h-index

  2. KH
    Kai‐Cheng Hsu

    Taipei Medical University, Taiwan

    1 publications · 24 citations

    1

    h-index

  3. LH
    Luqi Huang

    Chinese Academy of Medical Sciences & Peking Union Medical College, China

    1 publications · 19 citations

    1

    h-index

  4. CY
    Changwon Yoo

    Florida International University, United States

    1 publications · 35 citations

    1

    h-index

  5. TU
    Tsuyoshi Uehara

    University of the Ryukyus, Japan

    1 publications · 23 citations

    1

    h-index

1–5 of 310

Venues

  1. Scientific Reports

    2 publications · 60 citations

    2

    h-index

  2. PLoS ONE

    2 publications · 47 citations

    2

    h-index

  3. Antimicrobial Agents and Chemotherapy

    AAC · 2 publications · 108 citations

    2

    h-index

  4. Molecular BioSystems

    2 publications · 37 citations

    2

    h-index

  5. The Medical Journal of Australia

    MJA · 1 publications · 43 citations

    1

    h-index

1–5